Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Total Current Liabilities (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Total Current Liabilities for 5 consecutive years, with $2.4 million as the latest value for Q3 2020.

  • Quarterly Total Current Liabilities fell 94.22% to $2.4 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Sep 2020, down 94.22% year-over-year, with the annual reading at $1.9 million for FY2019, 88.44% down from the prior year.
  • Total Current Liabilities for Q3 2020 was $2.4 million at Forte Biosciences, down from $3.4 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $41.7 million in Q3 2019, with the low at $1.9 million in Q4 2019.
  • Average Total Current Liabilities over 5 years is $14.8 million, with a median of $15.6 million recorded in 2017.
  • The sharpest move saw Total Current Liabilities surged 186.05% in 2019, then tumbled 94.22% in 2020.
  • Over 5 years, Total Current Liabilities stood at $14.4 million in 2016, then grew by 20.5% to $17.3 million in 2017, then decreased by 4.59% to $16.5 million in 2018, then plummeted by 88.44% to $1.9 million in 2019, then increased by 26.1% to $2.4 million in 2020.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $2.4 million, $3.4 million, and $12.6 million for Q3 2020, Q2 2020, and Q1 2020 respectively.